title: Genital herpes in adolescents.
abstract: Herpes simplex virus (HSV) infections occur commonly among adolescents. Most HSV-2 infections are genital, but genital herpes can be caused by either HSV-1 or HSV-2. Weighted means were calculated based on published seroprevalence data on adolescents from the United States and found HSV-1 rates of 53.1 percent for adolescent males and 49.4 percent for adolescent females. The weighted means for HSV-2 was 15 percent for adolescent females and 12 percent for adolescent males. Most individuals who are infected with HSV-2 are unaware of their infection. Healthcare providers of adolescents should consider genital herpes even when an adolescent presents with nonspecific genital symptoms. In this article, we review current recommendations for diagnosis and management and review the psychological sequelae that can be associated with having genital herpes. Finally, we discuss biomedical interventions that are being developed to help reduce the epidemic of HSV and the challenges that these interventions face with regard to implementation.
authors.affiliation: Department of Pediatrics and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555-0319, USA. baauslan@utmb.edu
authors.forename: Beth A
authors.initials: BA
authors.lastname: Auslander
authors.forename: Frank M
authors.initials: FM
authors.lastname: Biro
authors.forename: Susan L
authors.initials: SL
authors.lastname: Rosenthal
mesh_terms: D000293:Adolescent; D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D006558:Herpes Genitalis / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology* / Q000523:psychology; D022301:Herpes Simplex Virus Vaccines; D018259:Herpesvirus 1, Human; D018258:Herpesvirus 2, Human; D006801:Humans; D015994:Incidence; D008297:Male; D012307:Risk Factors; D016036:Seroepidemiologic Studies
chemical_list: D000998:Antiviral Agents; D022301:Herpes Simplex Virus Vaccines